Cambridge, United Kingdom

Chukuemeka Tennyson Ekwuru

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 8.2

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Chukuemeka Tennyson Ekwuru: Innovator in Cancer Research

Introduction

Chukuemeka Tennyson Ekwuru is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of cancer research, particularly through his innovative work on compounds that inhibit cell division cycle 7 (Cdc7) kinase activity. With a total of 5 patents to his name, Ekwuru's inventions are paving the way for new treatments in the fight against proliferative disorders.

Latest Patents

Ekwuru's latest patents include the development of pyrimidinone derivatives as Cdc7 inhibitors. These compounds, defined by specific formulas, function as inhibitors of the Cdc7 kinase enzyme activity. The invention also encompasses pharmaceutical compositions that include these compounds, which are intended for use in treating various proliferative disorders, including cancer. The implications of his work extend to other diseases or conditions where Cdc7 kinase activity plays a critical role.

Career Highlights

Throughout his career, Ekwuru has worked with prominent organizations such as Cancer Research Technology Limited and AstraZeneca. His experience in these companies has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Ekwuru's notable coworkers include Mark David Charles and Emma Louise Carswell. Their collaborative efforts have further advanced the research and development of innovative treatments in oncology.

Conclusion

Chukuemeka Tennyson Ekwuru's contributions to cancer research through his patented inventions highlight the importance of innovation in medical science. His work continues to inspire advancements in the treatment of proliferative disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…